(Q83636892)
Statements
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study (English)
Bruce E Strober
Yves Poulin
Francisco A Kerdel
Richard G Langley
Yihua Gu
Shiraz R Gupta
Martin M Okun